Evidence map›Paper›PMID 28861590›Full record

ReviewHNO2017

[Botulinum toxin in otorhinolaryngology - an update].

R Laskawi, A Olthoff

Abstract readReview
PubMed Publisher
In one paragraph

Review in HNO, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

R LaskawiKlinik für Hals‑, Nasen- und Ohrenheilkunde, Universitätsmedizin Göttingen, 37075, Göttingen, Deutschland. rlaskaw@gwdg.de.
A OlthoffPhoniatrie und Pädaudiologie, Klinik für Hals‑, Nasen- und Ohrenheilkunde, Universitätsmedizin Göttingen, Göttingen, Deutschland.
Universitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During recent decades, the clinical use of botulinum toxin has become increasingly well established. In the field of otorhinolaryngology there are many indications for which botulinum toxin can improve patients' quality of life. These include applications in the region of the head and neck muscles and the autonomic nervous system in patients suffering from movement disorders of special muscles and secretory disorders (salivary, lacrimal, and sweat glands). The present article presents an overview of well-established and new indications for application of botulinum toxin in the head and neck region.

Indexed as

Botulinum Toxins, Type AOtolaryngologyHumansQuality of LifeBotulinum Toxins, Type ABotulinum toxinDisorders of the autonomic nerve systemHead and neck movement disorders

Identifiers

PMID28861590
OpenAlexW2753106214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.